Trading by management and close relations of management

In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation) and commission delegated regulation (EU) 1052/2016 of 8 March 2016, Novozymes A/S, part of Novonesis Group reports the following transactions under ISIN DK0060336014, Novonesis (Novozymes) B shares under the symbol NSIS B. The released shares relate to the 2022 legacy Chr. Hansen restricted stock units (RSU) program.

Please read the full announcement in PDF.

You May Also Be Interested In

• Result of the auction of 2.00 per cent DGB 2028 and 2.25 per cent DGB 2035
• China Foreign Trade Industry Annual Mega-Event “XTransfer Summit 26” Concludes Successfully
• Brantone Veylor Launches Its European Strategic Expansion